(1)
Kolageri, S. .; Hemanth , S.; Parit, M. . In-Silico ADME Prediction and Molecular Docking Study of Novel Benzimidazole-1,3,4-Oxadiazole Derivatives As CYP51 Inhibitors for Antimicrobial Activity. J. Appl. Pharm. Res. 2022, 10, 28-38.